COLGATE PALMOLIVE CO Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Colgate Palmolive Co quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
Colgate Palmolive Co Operating Income (Loss) for the quarter ending September 30, 2024 was $1.07B, a 3.5% increase year-over-year.
Colgate Palmolive Co Operating Income (Loss) for the twelve months ending September 30, 2024 was $4.28B, a 37.3% increase year-over-year.
Colgate Palmolive Co annual Operating Income (Loss) for 2023 was $3.98B, a 37.7% increase from 2022.
Colgate Palmolive Co annual Operating Income (Loss) for 2022 was $2.89B, a 13.2% decline from 2021.
Colgate Palmolive Co annual Operating Income (Loss) for 2021 was $3.33B, a 14.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$4.28B	$1.07B	+$36M	+3.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-25
Q2 2024	$4.24B	$1.09B	+$118M	+12.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-26
Q1 2024	$4.12B	$1.05B	+$138M	+15.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-26
Q4 2023	$3.98B	$1.07B	+$870M	+431%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-15
Q3 2023	$3.11B	$1.03B	+$82M	+8.66%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-25
Q2 2023	$3.03B	$974M	+$90M	+10.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-26
Q1 2023	$2.94B	$909M	+$49M	+5.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-26
Q4 2022	$2.89B	$202M	-$163M	-44.7%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-15
Q3 2022	$3.06B	$947M	-$20M	-2.07%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-27
Q2 2022	$3.08B	$884M	-$112M	-11.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-28
Q1 2022	$3.19B	$860M	-$144M	-14.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-28
Q4 2021	$3.33B	$365M	-$604M	-62.3%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-15
Q3 2021	$3.94B	$967M	-$51M	-5.01%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-28
Q2 2021	$3.99B	$996M	+$50M	+5.29%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-29
Q1 2021	$3.94B	$1B	+$52M	+5.46%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-29
Q4 2020	$3.89B	$969M	+$38M	+4.08%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-16
Q3 2020	$3.85B	$1.02B	+$162M	+18.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-29
Q2 2020	$3.69B	$946M	+$58M	+6.53%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-30
Q1 2020	$3.63B	$952M	+$73M	+8.31%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$3.55B	$931M	+$40M	+4.49%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-17
Q3 2019	$3.51B	$856M	-$18M	-2.06%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-30
Q2 2019	$3.53B	$888M	-$58M	-6.13%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-31
Q1 2019	$3.59B	$879M	-$104M	-10.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	$3.69B	$891M	-$69M	-7.19%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-18
Q3 2018	$3.76B	$874M	-$83M	-8.67%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-01
Q2 2018	$3.85B	$946M	+$68M	+7.75%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-26
Q1 2018	$3.78B	$983M	+$71M	+7.79%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-26
Q4 2017	$3.71B	$960M	-$113M	-10.5%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-21
Q3 2017	$3.82B	$957M	-$114M	-10.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-26
Q2 2017	$3.93B	$878M	-$66M	-6.99%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-27
Q1 2017	$4B	$912M	+$45M	+5.19%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-27
Q4 2016	$3.96B	$1.07B	+$1.21B		Oct 1, 2016	Dec 31, 2016	10-K	2019-02-21
Q3 2016	$2.74B	$1.07B	-$65M	-5.72%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-27
Q2 2016	$2.81B	$944M	+$12M	+1.29%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-21
Q1 2016	$2.8B	$867M	+$7M	+0.81%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-28
Q4 2015	$2.79B	-$139M	-$1.13B	-114%	Oct 1, 2015	Dec 31, 2015	10-K/A	2018-02-21
Q3 2015	$3.92B	$1.14B	+$188M	+19.8%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-27
Q2 2015	$3.74B	$932M	-$48M	-4.9%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-07-28
Q1 2015	$3.78B	$860M	+$226M	+35.6%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-28
Q4 2014	$3.56B	$995M	+$103M	+11.5%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-23
Q3 2014	$3.45B	$948M	-$68M	-6.69%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-10-30
Q2 2014	$3.52B	$980M	+$74M	+8.17%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-07-30
Q1 2014	$3.45B	$634M	-$108M	-14.6%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-30
Q4 2013	$3.56B	$892M	-$50M	-5.31%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-18
Q3 2013	$3.61B	$1.02B	-$11M	-1.07%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-24
Q2 2013	$3.62B	$906M	-$76M	-7.74%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-07-31
Q1 2013	$3.69B	$742M	-$196M	-20.9%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-04-25
Q4 2012	$3.89B	$942M	+$19M	+2.06%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-19
Q3 2012	$3.87B	$1.03B	-$8M	-0.77%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-24
Q2 2012	$3.88B	$982M	+$14M	+1.45%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-07-25
Q1 2012	$3.86B	$938M	+$23M	+2.51%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-04-25
Q4 2011	$3.84B	$923M	+$18M	+1.99%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-20
Q3 2011	$3.82B	$1.04B	+$77M	+8.04%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-10-25
Q2 2011	$3.75B	$968M	+$20M	+2.11%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-07-26
Q1 2011	$3.73B	$915M	+$237M	+35%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-04-26
Q4 2010	$3.49B	$905M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-21
Q3 2010		$958M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-10-27
Q2 2010		$948M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-07-28
Q1 2010		$678M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-04-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.